Anosmia, the loss of the sense of smell, is usually associated with rhinopathies and has been reported as a common symptom of COVID‐19. There is no specific drug to treat… Click to show full abstract
Anosmia, the loss of the sense of smell, is usually associated with rhinopathies and has been reported as a common symptom of COVID‐19. There is no specific drug to treat this condition, although some evidence suggests that melatonin could promote the recovery of olfactory sensory neurons.
               
Click one of the above tabs to view related content.